SynthesisCancer2026

The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta-analysis.

Yiwen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.